Missourians face risk in counterfeit medicines.
GlaxoSmithKline. Thomas.f.lawler@gsk.com
Thomas
T
Lawler
D058110:Counterfeit Drugs / Q000009:adverse effects / Q000191:economics / Q000600:supply & distribution* / Q000627:therapeutic use*; D003415:Crime; D006801:Humans; D008509:Medication Systems / Q000592:standards*; D008923:Missouri; D014481:United States; D014486:United States Food and Drug Administration
D058110:Counterfeit Drugs